Press release
Erectile Dysfunction Drugs Market Size Set for Exponential Growth, Predicted to Surpass USD 5.1 Billion by 2032 | CAGR of 6.5%
Erectile Dysfunction Drugs Market
The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐ซ๐๐๐ญ๐ข๐ฅ๐ ๐๐ฒ๐ฌ๐๐ฎ๐ง๐๐ญ๐ข๐จ๐ง ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ?
The global erectile dysfunction drugs market is driven by factors such as an Increase in the prevalence of erectile dysfunction due to diabetes, obesity, and sedentary lifestyle, easy accessibility of erectile dysfunction drugs, and surge in awareness about erectile dysfunction. However, side effects associated with erectile dysfunction drugs such as nasal congestion, blurred vision, and flushing are hampering the erectile dysfunction drugs market growth. On the contrary, an increase in R&D activities in erectile dysfunction treatment, high growth potential in developing countries, and a rise in new erectile dysfunction drugs launch are expected to offer remunerative opportunities for expansion of the erectile dysfunction drugs market during the forecast period.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/382
๐๐จ๐ฉ ๐๐ซ๐๐๐ญ๐ข๐ฅ๐ ๐๐ฒ๐ฌ๐๐ฎ๐ง๐๐ญ๐ข๐จ๐ง ๐๐ซ๐ฎ๐ ๐ฌ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
โข Pfizer Inc.
โข Eli Lilly and Company
โข Teva Pharmaceutical Industries Ltd.
โข Sanofi
โข Bayer AG
โข Vivus LLC.
โข Adamed
โข Glenmark Pharmaceuticals Limited
โข Cipla Ltd
โข Sun Pharmaceutical Industries Limited
๐๐ซ๐๐๐ญ๐ข๐ฅ๐ ๐๐ฒ๐ฌ๐๐ฎ๐ง๐๐ญ๐ข๐จ๐ง ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: -
Based on product, the sildenafil segment held the highest market share in 2022, accounting for more than half of the global erectile dysfunction drugs market revenue and is estimated to maintain its leadership status throughout the forecast period. The same segment is projected to manifest the highest CAGR of 7.1% from 2023 to 2032. This is because it is easily accessible, highly potent to treat erectile dysfunction, and it is available in various concentrations such as Sildenafil 20mg, sildenafil 50mg, and sildenafil 100mg.
Based on mode of administration, the oral medication segment held the highest market share in 2022, accounting for more than four-fifths of the global erectile dysfunction drugs market revenue and is estimated to dominate the market in terms of revenue during the forecast period. The same segment is estimated to manifest the highest CAGR of 6.8% from 2023 to 2032, owing to increase in demand for oral medications as it is easy to administer, highly effective, and widely available in the market as compared with injectable medication.
Based on the distribution channel, the hospital pharmacy segment accounted for the largest share in 2022, contributing to more than two-fifths of the global erectile dysfunction drugs market revenue and is expected to rule the roost in terms of revenue throughout the forecast timeframe. This segment is projected to maintain the highest CAGR of 7.2% during the forecast period, owing to an increase in the sale of prescription medication from hospitals and the availability of erectile dysfunction drugs in various concentrations through hospital pharmacies.
Based on region, North America held the highest market share in terms of revenue in 2022, accounting for around two-fifths of the global erectile dysfunction drugs market revenue and is estimated to lead the trail throughout the forecast period. The growth is attributed to an increase in accessibility of erectile dysfunction drugs and rise in product approvals. However, the Asia-Pacific region is expected to witness the fastest CAGR of 7.5% from 2023 to 2032, owing to rise in awareness of erectile dysfunction, surge in healthcare expenditure, and an increase in the prevalence of various chronic diseases such as diabetes and obesity.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/382
Our Market Research Solution Provides You Answer to Below Mentioned Question:
โข Which are the driving factors responsible for the growth of market?
โข Which are the roadblock factors of this market?
โข What are the new opportunities, by which market will grow in coming years?
โข What are the trends of this market?
โข Which are main factors responsible for new product launch?
โข How big is the global & regional market in terms of revenue, sales and production?
โข How far will the market grow in forecast period in terms of revenue, sales and production?
โข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โข Which region has more opportunities?
By Region Outlook
โข North America
(U.S., Canada, Mexico)
โข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Erectile Dysfunction Drugs Market Size Set for Exponential Growth, Predicted to Surpass USD 5.1 Billion by 2032 | CAGR of 6.5% here
News-ID: 3484126 • Views: โฆ
More Releases from Allied Market Research (AMR)
U.S. Contrast Injector Systems Market Size (USD 693.70 Million Revenue by 2032) โฆ
Contrast injector system is a medical diagnostic device that uses a contrast medium to create visual representations of the interior of human body to diagnose, monitor, or treat clinical problems. Contrast media is preferred over conventional image processing, as it improves the contrast structures or visibility of fluids within the body. It is utilized to make blood vessels and the gastrointestinal tract more visible.
Allied Market Research has published a studyโฆ
U.S. Healthcare IT Market Size (USD 344.07 billion Revenue by 2030) Growing Rapi โฆ
Allied Market Research published a report, titled, "U.S. Healthcare IT Market By Product Type (Healthcare Provider Solutions, Healthcare Payer Solutions, and HCIT Outsourcing Services) and End User (Healthcare Providers and Healthcare Payers): Opportunity Analysis and Industry Forecast, 2021-2030." According to the report, the U.S. Healthcare IT Market Size was valued at USD 96.93 billion in 2020 and it is estimated to surpass around USD 344.07 billion by 2030, with aโฆ
Battery Swapping Market Growth, Competitive Analysis, Prospects, And Top Key Pla โฆ
The battery swapping market size was valued at $120.3 million in 2022, and battery swapping industry is estimated to reach $642.7 million by 2032, growing at a CAGR of 18.3% from 2023 to 2032.
Battery swapping is a place at which an electric vehicle's discharged battery or battery pack may be immediately swapped for a fully charged one, eliminating the delay involved in waiting for a vehicle's battery to charge. Batteryโฆ
Proteomics Market Soars: From $23.7 Billion to $98 Billion by 2031
According to a new report published by Allied Market Research, titled, "Proteomics Market," The Proteomics Market Size was valued at $23,654.34 million in 2021, and is projected to reach $98,051.83 million by 2031, growing at a CAGR of 15.2% from 2022 to 2031.
Proteomics studies the interactions, functions, compositions, and structures of proteins and their cellular activities. Proteomics provides a better understanding of the structure and function of the organism thanโฆ
More Releases for Erectile
Global Erectile Dysfunction Devices Market Report
As per GME studies, on the Global Erectile Dysfunction Devices Market, it is analyzed that the market will grow at a CAGR of 6.5%. Erectile dysfunction incidence increases with growing age, about 5-10% of men under 40 years are the possible suspects for the dysfunctionality. This is projected to drive the ED device market in the coming years also. Raising the aforementioned disease prevalence and the growing percentage of tobaccoโฆ
50 Open Clinical Studies Presently, To Treat Erectile Dysfunction To Boost The E โฆ
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a ratioโฆ
Erectile Dysfunction Drugs Market Size, Erectile Dysfunction Drugsmarket Share, โฆ
According to a new study published by Polaris Market Research the global erectile dysfunction drugs market is anticipated to reach USD 2.63 billion by 2025.
Request for Sample of This Research Report @ https://bit.ly/2NXzatD
Top Key Players:-
Bayer AG
Pfizer
Eli Lilly & Co.
Vivus, Inc.
S.K. Chemicals Co. Ltd.
Dong-A Pharmaceutical Co. Ltd
Meda Pharmaceuticals
Apricus Biosciences
Make an inquiry before buying this report @ https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market/inquire-before-buying
According to a new study published by Polaris Market Research the global erectile dysfunctionโฆ
Erectile Dysfunction Market Industry Forecast till 2024
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with aโฆ
Erectile Dysfunction: A Prominent Age Related Disorder
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with aโฆ
Erectile Dysfunction - Pipeline Review, H2 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as โErectile Dysfunction - Pipeline Review, H2 2017โ.ย Erectile dysfunction, or ED, is the inability of a man to have an erection hard enough to have sexual intercourse. It can also be known as impotence.
Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1246564
The predisposing factors include tobacco usage, overweight, injuries, drug and alcohol use and medications, including antidepressants,โฆ
